Evidence map›Paper›PMID 40244561›Full record

ReviewAdvanced materials (Deerfield Beach, Fla.)2025

Materials Advances in Devices for Heart Disease Interventions.

Gagan K Jalandhra, Lauryn Srethbhakdi, James Davies, Chi Cong Nguyen, Phuoc Thien Phan, Zachary Och, Aditya Ashok, Khoon S Lim, Hoang-Phuong Phan, Thanh Nho Do and 2 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Advanced materials (Deerfield Beach, Fla.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. 3D Printing and Electrospinning of PLLA-ACS biomaterials science & engineering · 2026
    Article
  2. Smart Catheters for Diagnosis, Monitoring, and Therapy.Advanced healthcare materials · 2026
    Review
  3. Review
  4. Materials Advances in Devices for Heart Disease Interventions.Advanced materials (Deerfield Beach, Fla.) · 2025
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Gagan K JalandhraGraduate School of Biomedical Engineering, University of New South Wales, Sydney, NSW, 2052, Australia.ORCID https://orcid.org/0009-0005-5380-9334
Lauryn SrethbhakdiGraduate School of Biomedical Engineering, University of New South Wales, Sydney, NSW, 2052, Australia.
James DaviesGraduate School of Biomedical Engineering, University of New South Wales, Sydney, NSW, 2052, Australia.
Chi Cong NguyenGraduate School of Biomedical Engineering, University of New South Wales, Sydney, NSW, 2052, Australia.
Phuoc Thien PhanGraduate School of Biomedical Engineering, University of New South Wales, Sydney, NSW, 2052, Australia.
Zachary OchGraduate School of Biomedical Engineering, University of New South Wales, Sydney, NSW, 2052, Australia.ORCID https://orcid.org/0009-0003-5499-0257
Aditya AshokGraduate School of Biomedical Engineering, University of New South Wales, Sydney, NSW, 2052, Australia.
Khoon S LimSchool of Medical Sciences, University of Sydney, Sydney, NSW, 2006, Australia.ORCID https://orcid.org/0000-0002-2486-196X
Hoang-Phuong PhanSchool of Mechanical and Manufacturing Engineering, University of New South Wales, Sydney, NSW, 2052, Australia.ORCID https://orcid.org/0000-0002-1724-5667
Thanh Nho DoGraduate School of Biomedical Engineering, University of New South Wales, Sydney, NSW, 2052, Australia.
Nigel H LovellGraduate School of Biomedical Engineering, University of New South Wales, Sydney, NSW, 2052, Australia.ORCID https://orcid.org/0000-0003-1637-1079
Jelena Rnjak-KovacinaGraduate School of Biomedical Engineering, University of New South Wales, Sydney, NSW, 2052, Australia.ORCID https://orcid.org/0000-0001-6121-4676

Funding

Australian Research Council DP230101312Australian Research Council FT210100668Australian Research Council FT23010249Australian Research Council FT240100203HemoRhythmics Inc. PS73051NSW Health: Cardiovascular Research Capacity Program H21/174585NSW Health: Cardiovascular Research Capacity Program H22/98586UNSW Scientia Program, and UNSW 3Rs Grants RG192608-L
6 · The paper itself

Abstract

Heart disease encompasses a range of conditions that affect the heart, including coronary artery disease, arrhythmias, congenital heart defects, heart valve disease, and conditions that affect the heart muscle. Intervention strategies can be categorized according to when they are administered and include: 1) Monitoring cardiac function using sensor technology to inform diagnosis and treatment, 2) Managing symptoms by restoring cardiac output, electrophysiology, and hemodynamics, and often serving as bridge-to-recovery or bridge-to-transplantation strategies, and 3) Repairing damaged tissue, including myocardium and heart valves, when management strategies are insufficient. Each intervention approach and technology require specific material properties to function optimally, relying on materials that support their action and interface with the body, with new technologies increasingly depending on advances in materials science and engineering. This review explores material properties and requirements driving innovation in advanced intervention strategies for heart disease and highlights key examples of recent progress in the field driven by advances in materials research.

Indexed as

Biocompatible MaterialsHeart DiseasesAnimalsHumansBiocompatible Materialsbiomaterialscardiovascular diseasedevicesheart diseasetissue engineering

Identifiers

PMID40244561
PMCPMC12243731

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.